CRISPR in Drug Discovery 2021

Posters

Lorena Boquete Vilarino
MRC Laboratory of Molecular Biology
1A genome wide CRISPR/Cas9 screen for activators of dendritic cells
Lorena Boquete Vilarino
MRC Laboratory of Molecular Biology
1A genome wide CRISPR/Cas9 screen for activators of dendritic cells
Sabeeta Zafar
STEMCELL Technologies
2CRISPR-Cas9 Gene Editing of CDK5RAP2 in Human Pluripotent Stem Cells, Derivation of Genetically Stable Clonal Lines And Formation of Cerebral Organoids Using The Stemdiff™ Human Cerebral Organoid Culture System
Francesca Tasca
LUMC
Netherlands
3Homology-directed safe harbour insertion of transgenes encoding full-length dystrophin through high-capacity adenoviral vector delivery of CRISPR-Cas9 nucleases and donor DNA
Andrew Green
Eurofins DiscoverX
4Detection of Endogenous Protein Turnover Induced by Targeted Degraders
Antonio Carusillo
Center for Transfusion Medicine and Gene Therapy
Germany
5Modulation of DNA repair pathways by HDR-CRISPR promotes seamless genome editing in primary human hematopoietic cells
Antonio Carusillo
Center for Transfusion Medicine and Gene Therapy
Germany
5Modulation of DNA repair pathways by HDR-CRISPR promotes seamless genome editing in primary human hematopoietic cells
Kris Coupland
Nexcelom Bioscience Ltd
6Cellaca MX A Novel Instrument for High Throughput High Speed Cell Counting Concentration and Viability
Christian Parker
Novartis
Switzerland
7Genome-wide CRISPR-Cas9 screening identify key nodes regulating the NLRP3 Inflammasome
Christian Parker
Novartis
Switzerland
7Genome-wide CRISPR-Cas9 screening identify key nodes regulating the NLRP3 Inflammasome
Andrew Ravanelli
Merck KGaA
United States
8Forward Genetic Screening and Single Cell Analysis with CRISPRi Transcriptional Repressors
Sandra Wimberger
AstraZeneca
Sweden
9Modulation of the DNA Damage Response to Enhance Targeted Integration at CRISPR/Cas9-mediated DNA Double Strand Breaks
Jonathan Seager
Horizon Discovery
10Functional Genomic Screening with CRISPR technologies
Ricky Trigg
GSK
11Development of screening in CD4+ T cells to identify drug targets for immune-mediated inflammatory diseases
Ricky Trigg
GSK
11Development of screening in CD4+ T cells to identify drug targets for immune-mediated inflammatory diseases
Nadja Bischoff
University of Copenhagen
Denmark
12Comparison of methods to study gene-to-gene variation of HDR promoting inhibitor effects
Pedro Ramos
i3S - IBMC; ICBAS
Portugal
13What do people think about genetic engineering: a systematic review of post-CRISPR questionnaires
Jenna Persson
SciLifeLab
Sweden
14CRISPR/Cas9 screening at the CRISPR-based Functional Genomics facility, SciLifeLab
Carsten Brock
Eurofins Discovery
France
15Optimized PAR2 assay using HT-29 PAR1 KO cells generated by CRISPR
Jasper Komen
AstraZeneca
16CRISPR KO in HSPCs to evaluate hemetox target safety liabilities: proof of concept
Anchala Kumari
Jawaharlal Nehru University
India
17Bleomycin exhibits dual inhibition towards amyloid aggregation in β-amyloid and hIAPP
Count: 21